Predictive Oncology (POAI) Competitors $1.09 -0.01 (-0.91%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.03 -0.06 (-5.14%) As of 08:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock POAI vs. TELA, COCH, BDMD, DXR, POCI, ECOR, DRIO, MDAI, PTHL, and NMTCShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include TELA Bio (TELA), Envoy Medical (COCH), Baird Medical Investment (BDMD), Daxor (DXR), Precision Optics (POCI), electroCore (ECOR), DarioHealth (DRIO), Spectral AI (MDAI), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), and NeuroOne Medical Technologies (NMTC). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. TELA Bio Envoy Medical Baird Medical Investment Daxor Precision Optics electroCore DarioHealth Spectral AI Pheton Holdings Ltd Class A Ordinary Shares NeuroOne Medical Technologies TELA Bio (NASDAQ:TELA) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation. Do insiders & institutionals have more ownership in TELA or POAI? 94.3% of TELA Bio shares are owned by institutional investors. Comparatively, 9.0% of Predictive Oncology shares are owned by institutional investors. 6.0% of TELA Bio shares are owned by insiders. Comparatively, 3.4% of Predictive Oncology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer TELA or POAI? TELA Bio presently has a consensus target price of $7.25, suggesting a potential upside of 421.58%. Predictive Oncology has a consensus target price of $3.00, suggesting a potential upside of 175.23%. Given TELA Bio's stronger consensus rating and higher probable upside, equities analysts clearly believe TELA Bio is more favorable than Predictive Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community favor TELA or POAI? Predictive Oncology received 89 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.07% of users gave TELA Bio an outperform vote while only 64.22% of users gave Predictive Oncology an outperform vote. CompanyUnderperformOutperformTELA BioOutperform Votes6074.07% Underperform Votes2125.93% Predictive OncologyOutperform Votes14964.22% Underperform Votes8335.78% Is TELA or POAI more profitable? TELA Bio has a net margin of -60.49% compared to Predictive Oncology's net margin of -1,012.32%. Predictive Oncology's return on equity of -286.30% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-60.49% -556.18% -63.13% Predictive Oncology -1,012.32%-286.30%-122.11% Which has stronger valuation & earnings, TELA or POAI? Predictive Oncology has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$71.22M0.77-$46.66M-$1.41-0.99Predictive Oncology$1.62M6.00-$13.98M-$3.05-0.36 Which has more risk & volatility, TELA or POAI? TELA Bio has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Does the media prefer TELA or POAI? In the previous week, Predictive Oncology had 4 more articles in the media than TELA Bio. MarketBeat recorded 5 mentions for Predictive Oncology and 1 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.00 beat Predictive Oncology's score of -0.67 indicating that TELA Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Predictive Oncology 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative SummaryTELA Bio beats Predictive Oncology on 11 of the 18 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologySurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.74M$9.51B$5.38B$8.39BDividend YieldN/A1.61%5.21%4.10%P/E Ratio-0.3620.8726.7619.71Price / Sales6.0063.88389.94117.54Price / CashN/A19.6738.2534.62Price / Book0.535.056.804.50Net Income-$13.98M$284.66M$3.23B$248.18M7 Day Performance-0.91%-0.47%1.52%0.23%1 Month Performance22.16%2.15%10.04%12.39%1 Year Performance-32.72%-21.59%16.73%7.07% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology2.0362 of 5 stars$1.09-0.9%$3.00+175.2%-33.5%$9.74M$1.62M-0.3630News CoverageGap UpTELATELA Bio1.8445 of 5 stars$1.01-6.5%$7.25+617.8%-77.3%$39.95M$69.30M-0.60120COCHEnvoy Medical1.7338 of 5 stars$1.67-1.5%$9.13+448.0%-47.5%$35.51M$212,000.00-1.2134BDMDBaird Medical InvestmentN/A$5.35+3.3%N/AN/A$35.22M$33.05M0.00N/ADXRDaxor3.8069 of 5 stars$7.26-6.3%$25.00+244.4%-19.8%$35.12M$2.13M0.0037POCIPrecision Optics0.6741 of 5 stars$4.58-1.1%N/A-36.3%$35.11M$18.68M-7.1680Earnings ReportGap DownHigh Trading VolumeECORelectroCore2.9316 of 5 stars$4.82+3.7%$25.50+429.0%-27.6%$34.67M$25.18M-2.6350Positive NewsHigh Trading VolumeDRIODarioHealth1.6487 of 5 stars$0.76+1.3%$1.50+97.4%-61.9%$31.59M$27.04M-0.81200Analyst ForecastMDAISpectral AI2.9014 of 5 stars$1.36+9.7%$4.75+249.3%-21.6%$31.39M$29.58M-2.0983Positive NewsAnalyst RevisionGap UpPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$4.76+8.4%N/AN/A$31.33M$448,196.000.0011High Trading VolumeNMTCNeuroOne Medical Technologies1.7339 of 5 stars$0.62+1.2%$1.45+132.8%-42.2%$29.51M$5.75M-2.4020Gap UpHigh Trading Volume Related Companies and Tools Related Companies TELA Bio Competitors Envoy Medical Competitors Baird Medical Investment Competitors Daxor Competitors Precision Optics Competitors electroCore Competitors DarioHealth Competitors Spectral AI Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors NeuroOne Medical Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POAI) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy POAI Stock Free POAI Stock Alerts